Peptide Bias and Marketing Claims
Recognising how marketing bias can distort peptide claims and how to find credible information.
Last updated: 12 April 2026
Conflicts of interest
Suppliers have financial incentive to make their peptides look good. Manufacturers benefit from positive studies. Media outlets attract readers with sensational claims. When reading about a peptide, always ask: who is claiming this, and what do they benefit?
Undisclosed financial relationships bias claims toward optimism.
Common marketing tactics
Cherry-picking positive studies while ignoring negative ones. Exaggerating effect sizes. Using testimonials and before-and-after photos. Making vague 'natural' or 'safe' claims. Presenting preliminary research as proven fact.
These tactics exploit cognitive biases and selective attention.
Media sensationalism
Headlines often overstate research findings. A study showing 'a peptide was investigated for X' becomes 'new peptide treats X'. Media outlets prioritise engagement over accuracy.
Read the original research paper, not the media summary.
Finding credible information
Peer-reviewed journals provide scrutiny. Independent review sites with transparency about funding are more trustworthy. Educational institutions are less biased than suppliers. Always check author affiliations and funding sources.